Abiopharma

Cactus Announces First Quarter 2026 Results

Viridian Therapeutics, Inc. - Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

MGE Energy, Inc. Prices Public Offering of 3,300,331 Shares of Common Stock

Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

McEwen Generates Strong Q1 Results & Advances Multi-Asset Growth Strategy; Net Income $33.4M ($0.56 per Share) vs. Net Loss $6.3M ($0.12 per Share) in Q1 2025; Internally Funding Key Projects to Double Production by 2030

Wrightbus Selects Ballards FCmove®‑SC Engine to Power Its Next‑Generation Hydrogen Bus Platform USA - English USA - English

SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)